Makinen
TL2 Member · Frankfurt, DE
UK-based. Mostly the access and pricing categories.
Joined 8 July 2025 · last posted 9d · groups: regional-uk
86Posts here
2Topics
0Solutions
249Likes received
327Likes given
20Badges
128Days visited
1.4kPosts read
Most-liked posts
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Started this topic · Practice › Dosing & titration · 11 Oct 2024 · 35 likes The question in the title: Revisiting: Holding a dose indefinitely: is there a documented downside? I will give what I have already checked below so nobody repeats it.…
-
Reading order for a first week here, and what to skip until later Replied, post #53 · Start Here › Welcome · 26 Mar 2025 · 32 likes Reading order sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
[2026 update] New subcategory: rationale and scope Replied, post #69 · Meta › Announcements · 16 Dec 2024 · 32 likes This is the answer, and the reason it is the answer is the more useful part.
-
About the Tirzepatide category Replied, post #5 · Compounds › Tirzepatide · 25 Jun 2025 · 28 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #81 · Analytics › Mass spectrometry · 24 Mar 2026 · 26 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #53 · Access › Insurance & coverage · 4 Jul 2026 · 25 likes Two sentences on Prior authorisation and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
Where this member posts
| Category | Posts | Share |
|---|---|---|
| Practice | 18 | 21% |
| Evidence | 11 | 13% |
| Compounds | 9 | 10% |
| Analytics | 9 | 10% |
| Research Methods | 6 | 7% |
| Documentation | 4 | 5% |
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| First Reply | bronze | 10 Jul 2025 |
| Basic User | bronze | 12 Jul 2025 |
| Read the Guidelines | bronze | 14 Jul 2025 |
| First Link | bronze | 21 Jul 2025 |
| First Topic | bronze | 24 Jul 2025 |
| Welcome | bronze | 26 Jul 2025 |
| Member | bronze | 28 Jul 2025 |
| Generous | bronze | 31 Jul 2025 |
| First Quote | bronze | 11 Aug 2025 |
| Sourced | bronze | 12 Aug 2025 |
| Asked Well | bronze | 15 Aug 2025 |
| Reader | bronze | 20 Aug 2025 |
| First Tag | bronze | 11 Sep 2025 |
| Editor | bronze | 10 Oct 2025 |
| Logistics | bronze | 7 Dec 2025 |
| Nice Topic | bronze | 21 Dec 2025 |
| Nice Post | bronze | 22 Dec 2025 |
| Good Post | silver | 24 Dec 2025 |
| Good Topic | silver | 3 Feb 2026 |
| Anniversary | silver | 8 Jul 2026 |